Nike v. Lululemon: a landmark patent battle in the footwear industry
The ongoing legal battle between Nike and Lululemon has become a focal point in the sportswear industry, highlighting the increasing importance of intellectual property (IP) protection in a highly competitive market. The case, which began in January 2023, centers...
Pfizer and BioNTech secure PTAB victory against Moderna amid global patent disputes
Pfizer and BioNTech scored a significant win at the US Patent Trial and Appeal Board (PTAB or the Board) over COVID-19 vaccine technology. The Board invalidated all challenged claims in two of Moderna's patents related to its Spikevax COVID-19 vaccine, citing strong...
Federal Circuit lowers barrier for ITC patent enforcement: a win for small biotech firms
In an important decision that has significant implications for patent enforcement in the biotherapeutic and cell culture arts, the Federal Circuit has reaffirmed the International Trade Commission’s (ITC) authority to block the importation of infringing. The ruling in...
Open source and AI from a community-based intellectual property perspective
We recently had the opportunity to speak with Keith Bergelt, the CEO of Open Invention Network (OIN). OIN is the largest patent non-aggression community in history and the forerunner to many other organizations that have been formed to collectively shield companies...
Letters Rogatory: a valuable tool for the collection of evidence across borders
The case involves a patent dispute between Pfizer Inc. and its subsidiaries (FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., and Wyeth LLC) (Petitioners) against Softgel Healthcare Private Limited (Respondent), an Indian company. The dispute centers around the alleged...
‘Squeeze argument’ in patent infringement: tamper-evident closure case
A recent judgment on 8 May 2024, by the Hon'ble High Court of Delhi, in Guala Closures SPA v. AGI Greenpac Limited sheds light on the strategic maneuver known as the 'squeeze argument' and its profound significance in patent infringement cases. This case underscores...
ERS Genomics and IRBM sign CRISPR/Cas9 license agreement
The license agreement provides IRBM access to CRISPR gene editing technology to be applied across its drug discovery services offering. Dublin, Ireland, and Rome, Italy, 20 May 2024 — ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, and IRBM, a leader in...
UPC referendum in Ireland postponed
The Irish Government has confirmed its decision to defer the date for the referendum for the ratification of the agreement on a Unified Patent Court (UPC), which was due to be held on 7 June 2024 to coincide with the European and Local elections. No alternative date...
Neuroscience nugget for Mental Health Awareness Week: moving with awareness
We all know that being active is important for our physical and mental health. However, I am going to look beyond the obvious benefits of being active and take a deeper dive into the field of neuroscience, which demonstrates the interconnectedness of our mind and body...
16th edition of Global IP Convention, Istanbul: India’s flagship event is now in Turkey
The Global Intellectual Property Conference (GIPC) is where brilliance meets influence. This isn't your average gathering; it's a convergence of thought leaders, industry titans, innovators, legal experts, and executives from Fortune 500 companies. Step into the...
Number of drone patents filed worldwide jumps 16% in past year
R&D in defense driving innovation in drone technology, alongside agriculture and logistics Russia filing significant number of patents as drones used in conflict AI is also a key part of the increase in drone patent filings. The number of global patents filed for...
EUIPO’s 5th IP Case Law Conference: an inside look
We were delighted to attend the EUIPO’s 5th IP Case Law Conference held in Alicante on the 29-30 of April 2024 – special thanks to EUIPO for the invitation and exceptional hospitality throughout the conference. Following a warm welcome from Master of Ceremony Thomas...
Legal dispute redefining COVID-19 vaccine patents and future of mRNA tech
The race for a COVID-19 vaccine in 2020 was a global effort, but the aftermath has seen a bitter legal battle erupt between pharmaceutical giants. In August 2022, Moderna, a pioneer in messenger RNA (mRNA) technology, launched a lawsuit against Pfizer and BioNTech,...
Delhi High Court awards Ericsson $29 million in SEP case
On 28 March 2024, the Delhi High Court concluded a decade-long litigation between Telefonaktiebolaget LM Ericsson (Ericsson) and Lava Intl. Ltd (Lava) by delivering a landmark judgment that Lava infringed Ericsson’s eight Standard Essential Patents (SEPs) relating to...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.